SPMS health costs are high, and higher still for younger patients and those with severe disability, a real-world study in ...

Obe-cel is under regulatory review in both the EU and the U.K., and the Company expects to receive notification of approval status from the Medicines and Healthcare products Regulatory Agency (MHRA) ...

Functional neurological disorder can be hard to distinguish from other conditions. Some patients feel misunderstood and their ...

New research highlights how multimorbidity significantly worsens survival and physical function in patients with systemic sclerosis, underscoring the need for holistic care strategies.

Learn about your workplace rights with a chronic illness, including ADA protections, FMLA leave, and how to request ...

Lifelong traveler and adventurer Robin Cohen was diagnosed with the neurological disease more than two decades ago, but she ...

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Scientists in Sweden have taken an important step forward in understanding how a very common virus, called Epstein-Barr virus ...

TGTX surges 200% in 2023 on Briumvi's MS success. With Q1'25 earnings ahead, see here for TGTX stock's sales trends, new ...